[1] |
World Health Organization.World Malaria Report 2016[R]. Geneva: WHO, 2016.
|
[2] |
Mita T, Tanabe K, Kita K.Spread and evolution of Plasmodium falciparum drug resistance[J]. Parasitol Int, 2009, 58(3): 201-209.
|
[3] |
Wang Z, Shrestha S, Li X, et al. Prevalence of K13-propeller polymorphisms in Plasmodium falciparum from China-Myanmar border in 2007-2012[J]. Malar J, 2015, 14: 168.
|
[4] |
官亚宜, 汤林华, 胡铃, 等. 海南恶性疟原虫分离株Pfcrt和Pfmdr1基因点突变的研究[J]. 中国寄生虫学与寄生虫病杂志, 2005, 23(3): 135-139.
|
[5] |
Alareqi LM, Mahdy MA, Lau YL, et al. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season[J]. Acta Trop, 2016, 162: 174-179.
|
[6] |
Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria[J]. Nature, 2013, 505(7481): 50-55.
|
[7] |
Takala-Harrison S, Jacob CG, Arze C, et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia[J]. J Infect Dis, 2015, 211(5): 670-679.
|
[8] |
White NJ.Malaria: a molecular marker of artemisinin resistance[J]. Lancet, 2014, 383(9927): 1439-1440.
|
[9] |
周瑞敏, 王轶楠, 钱丹, 等. 2015年河南省输入性恶性疟原虫Pfcrt基因的多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2016, 34(5): 399-404.
|
[10] |
Lim P, Alker AP, Khim N, et al. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia[J]. Malar J, 2009, 8: 11.
|
[11] |
Ranford-Cartwright LC, Johnston KL, Abdel-Muhsin AM, et al. Critical comparison of molecular genotyping methods for detection of drug-resistant Plasmodium falciparum[J]. Trans R Soc Trop Med Hyg, 2002, 96(5): 568-572.
|
[12] |
Taylor SM, Parobek CM, DeConti DK, et al. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study[J]. J Infect Dis, 2015, 211(5): 680-688.
|
[13] |
钱丹, 张红卫, 周瑞敏, 等. 河南省2009-2013年疟疾流行特征及趋势分析[J]. 中国热带医学, 2015, 15(1): 64-66.
|
[14] |
杨成运, 鲁德领, 周瑞敏, 等. 河南省2013年疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2014, 32(5): 370-372.
|
[15] |
贾西帅, 周水茂, 徐明星, 等. 武汉市输入性恶性疟原虫多药抗性基因1相关位点突变分析[J]. 中国寄生虫学与寄生虫病杂志, 2016, 34(6): 489-492.
|
[16] |
徐超, 魏庆宽, 李瑾, 等. 输入性恶性疟原虫耐药相关基因Pfcrt和Pfmdr1单倍型及突变分析[J]. 中国人兽共患病学报, 2016, 32(12): 1051-1057.
|
[17] |
Lobo E, de Sousa B, Rosa S, et al. Prevalence of Pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy[J]. Malar J, 2014, 13: 300.
|
[18] |
Naomi WL, Franklin K, Sheila AO, et al. In vitro and molecular surveillance for antimalarial drug resistance in Plasmodium falciparum parasites in Western Kenya reveals sustained artemisinin sensitivity and increased chloroquine sensitivity[J]. Antimicrob Agents Chemother, 2015, 59(12): 7540-7547.
|
[19] |
Noedl H, Se Y, Schaecher K, et al. Evidence of artemisinin-resistant malaria in western Cambodia[J]. N Engl J Med, 2008, 359(24): 2619-2620.
|
[20] |
Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria[J]. N Engl J Med, 2009, 361(5): 455-467.
|
[21] |
Nyunt MH, Hlaing T, Oo HW, et al. Molecular assessment of artemisinin resistance markers, polymorphisms in the K13 propeller, and a multidrug-resistance gene in the eastern and western border areas of Myanmar[J]. Clin Infect Dis, 2015, 60(8): 1208-1215.
|
[22] |
Win AA, Imwong M, Kyaw MP, et al. Erratum to: K13 mutations and Pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar[J]. Malar J, 2016, 15(1): 297.
|
[23] |
Feng J, Li J, Yan H, et al. Evaluation of antimalarial resistance marker polymorphism in returned migrant workers in China[J]. Antimicrob Agents Chemother, 2015, 59(1): 326-330.
|
[24] |
Kamau E, Campino S, Amenga-Etego L, et al. K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa[J]. J Infect Dis, 2015, 211(8): 1352-1355.
|